Recognition and Management of Metabolic Epilepsies - Takeaways - MDSpire

Recognition and Management of Metabolic Epilepsies

This video presents a clinically grounded overview of recent advances in neurogenetics and precision-based therapies for severe childhood-onset neurological disorders, including Dravet syndrome and related epileptic encephalopathies

  • April 7, 2026

Share

  • 1

    Recent advances in neurogenetics are enhancing the understanding of severe childhood-onset neurological disorders.

  • 2

    Single-gene mutations disrupt neuronal signaling and stability, leading to complex seizure phenotypes.

  • 3

    Traditional antiseizure therapies are limited, highlighting the need for disease-modifying approaches.

  • 4

    Emerging therapies include gene replacement, modulation, and RNA-based strategies with specific delivery challenges.

  • 5

    Rigorous clinical research and long-term follow-up are essential for the responsible translation of new therapies.

Original Source(s)

Recognition and Management of Metabolic Epilepsies

  • April 7, 2026

Related Content

Efficacy and Safety of Perampanel as the First Medication for Children with Newly Diagnosed Epilepsy: A Real-World Single-Center Prospective Observational Study

Ictal gamma increase shows preferential localization to seizure onset contacts in stereoelectroencephalography

Multimodal MRI Investigations of Cortical and Subcortical Structural Abnormalities and Their Cognitive Associations in Drug-Naïve Patients with SeLECTS